The pharmacokinetic pilot study in humans comparing QH Ubiquinol to the same QH Ubiquinol in the VESIsorb® delivery system demonstrated an increase of 696% in peak blood levels of Ubiquinol. The relative bioavailability calculated using the area under the curve was also increased by 485%.
|Kaneka QH||VESIsorb® Kaneka QH|
|Kaneka QH 100mg capsule|
|Kaneka QH 200mg capsule||Technology not available*|
|Patented Kaneka QH||Yes||Yes|
|Patented Water soluble Droplets||No||Yes|
|Peak Absorption||Standard QH||696% increase in peak blood levels (cmax) of Ubiquinol|
|Relative Bioavailability||Standard QH||489% increase in relative bioavailability calculated using the area under the curve (AUC 0-24h)|
* The Patented VESIsorb Delivery system improves the loading of the active dose of QH Ubiquinol by 200% compared to other delivery systems can only provide 100mg of QH Ubiquinol in a 1g capsule.
QH Ubiquinol is described as the “reduced form” of CoQ10. The body must take an extra step to convert CoQ10 (Ubiquinone) to QH Ubiquinol in the body. This is easily done when we are younger but becomes less efficient as we age or our bodies are under stress from disease and other conditions.
QH Ubiquinol, like CoQ10, is not easily absorbed into the body. Once in the body, QH Ubiquinol does not require the conversion step of CoQ10. Both CoQ10 and QH Ubiquinol benefit greatly from the increased absorption and improved bioavailability of the VESIsorb® delivery system.
|QH Ubiquinol without VESIsorb®||CoQsource® QH Ubiquinol with VESIsorb®|
|QH Ubiquinol drops sitting on the water||Colloidal droplet formation|
|Formula does not go into solution||100% in solution|
|Separation of ingredients||Completely homogenous colloidal solution
for optimal absorption!
Compare a standard QH Ubiquinol capsule squeezed into body temperature water to QH Ubiquinol in the VESIsorb® delivery system. Both capsules contain the very same Kaneka QH Ubiquinol yet the difference is dramatic.
A pharmacokinetic pilot study (single oral dose, crossover) in humans comparing QH Ubiquinol to the same QH Ubiquinol in the VESIsorb® delivery system (CoQsource® QH Ubiquinol exclusively from SourceOne) demonstrated an increase of 696% in peak blood levels (cmax) of ubiquinol. The relative bioavailability calculated using the area under the curve (AUC0-24h) was also increased by 485%.